News & Updates

Widely used Bazett formula overestimates corrected QT interval during an AF attack

26 Jan 2022

An atrial fibrillation (AF) attack does not substantially impact the corrected QT interval (QTc), a recent study suggests. Of existing formulae to correct QT, the Framingham formula achieves the best results while the Bazett formula appears to overestimate QTc during an AF attack.

Widely used Bazett formula overestimates corrected QT interval during an AF attack

26 Jan 2022

Obsessive-compulsive symptoms in clozapine-treated patients take a toll on their wellbeing

26 Jan 2022

Obsessive-compulsive symptoms appear to frequently occur among schizophrenic patients receiving treatment with clozapine, and these symptoms exert a negative effect on the patients’ wellbeing, a study reports.

Obsessive-compulsive symptoms in clozapine-treated patients take a toll on their wellbeing

26 Jan 2022

Binge watching TV tied to increased risk of VTE

26 Jan 2022 by

People who spend long hours (>4 hours a day) watching television (TV) have an increased risk of developing venous thromboembolism (VTE) than those who seldom watch TV, and this is independent of physical activity, according to a meta-analysis.

Binge watching TV tied to increased risk of VTE

26 Jan 2022

COVID-19 unlikely to be transmitted via breastfeeding, says small study

26 Jan 2022 by

SARS-CoV-2 RNA is infrequently detected in the breastmilk of mothers with proven or suspected COVID-19, but just the same, breastfeeding does not represent a risk factor for vertical transmission of the infection, according to data from a small study.

COVID-19 unlikely to be transmitted via breastfeeding, says small study

26 Jan 2022

Mirikizumab improves disease, symptom severity in patients with Crohn’s disease

26 Jan 2022 by

Treatment with the anti-interleukin-23p19 inhibitor mirikizumab led to significant improvements in patient-assessed disease severity and activity, as well as abdominal pain, in individuals with moderate-to-severe active Crohn’s disease, according to phase II data presented at the Crohn’s and Colitis Congress (CCC) 2022.

Mirikizumab improves disease, symptom severity in patients with Crohn’s disease

26 Jan 2022

OCT allows noninvasive assessment of pulsatile intracranial pressure

26 Jan 2022 by

Optical coherence tomography (OCT) can be used for the noninvasive measurement of pulsatile intracranial pressure, especially when using the OCT parameters peripapillary Bruch’s membrane angle and optic nerve head height, according to a recent study.

OCT allows noninvasive assessment of pulsatile intracranial pressure

26 Jan 2022

SARS-CoV-2 antibodies persist long after infection

26 Jan 2022

The majority of patients who contract SARS-CoV-2 infection develop antibodies, which remain in the blood for up to 15 months after infection, a study has found. Meanwhile, a negative antibody test is linked to re-infection.

SARS-CoV-2 antibodies persist long after infection

26 Jan 2022

Glycated albumin predicts haemorrhagic transformation in IVT patients

26 Jan 2022

Glycated albumin levels, as an estimator of prestroke glycaemic variability, is a good predictor of symptomatic haemorrhagic transformation in patients with intravenous thrombolysis (IVT), a recent study has found.

Glycated albumin predicts haemorrhagic transformation in IVT patients

26 Jan 2022

Second-line tisagenlecleucel renders no EFS benefit in aggressive B-cell lymphoma

25 Jan 2022 by

The anti-CD19 chimeric antigen receptor (CAR) T-cell treatment tisagenlecleucel did not improve event-free survival (EFS) compared with standard care in patients refractory or who had progressed following first-line therapy for aggressive B-cell non-Hodgkin’s lymphoma, results of the phase III BELINDA trial showed.

Second-line tisagenlecleucel renders no EFS benefit in aggressive B-cell lymphoma

25 Jan 2022

Hyperuricaemia ups death risk in ICU patients with sepsis

25 Jan 2022

In intensive care unit (ICU) patients with sepsis, hyperuricaemia correlates with significantly higher all-cause mortality and acute kidney injury, a recent study has found.

Hyperuricaemia ups death risk in ICU patients with sepsis

25 Jan 2022

News & Updates

Filter by Specialty:

Specialty:

Widely used Bazett formula overestimates corrected QT interval during an AF attack

Widely used Bazett formula overestimates corrected QT interval during an AF attack

Obsessive-compulsive symptoms in clozapine-treated patients take a toll on their wellbeing

Obsessive-compulsive symptoms in clozapine-treated patients take a toll on their wellbeing

Binge watching TV tied to increased risk of VTE

Binge watching TV tied to increased risk of VTE

COVID-19 unlikely to be transmitted via breastfeeding, says small study

COVID-19 unlikely to be transmitted via breastfeeding, says small study

Mirikizumab improves disease, symptom severity in patients with Crohn’s disease

Mirikizumab improves disease, symptom severity in patients with Crohn’s disease

OCT allows noninvasive assessment of pulsatile intracranial pressure

OCT allows noninvasive assessment of pulsatile intracranial pressure

SARS-CoV-2 antibodies persist long after infection

SARS-CoV-2 antibodies persist long after infection

Glycated albumin predicts haemorrhagic transformation in IVT patients

Glycated albumin predicts haemorrhagic transformation in IVT patients

Second-line tisagenlecleucel renders no EFS benefit in aggressive B-cell lymphoma

Second-line tisagenlecleucel renders no EFS benefit in aggressive B-cell lymphoma

Hyperuricaemia ups death risk in ICU patients with sepsis

Hyperuricaemia ups death risk in ICU patients with sepsis